Search Prime Grants

W81XWH2210331

Project Grant

Overview

Grant Description
Mercapturic acid pathway inhibitors as a novel treatment for ovarian cancer.
Awardee
Beckman Research Institute Of The City Of Hope
Grant Program (CFDA)
12.420 - Military Medical Research and Development
Awarding Agency
U.S. Army Medical Research Acquisition Activity (USAMRAA) [DoD - USA - MEDCOM - MRDC]
Funding Agency
Medical Command (MEDCOM) [DoD - USA]
Place of Performance
Duarte, California 910103012 United States
Geographic Scope
Single Zip Code
Related Opportunity
0011754899
Beckman Research Institute Of The City Of Hope was awarded Project Grant W81XWH2210331 worth $1,056,000 from Medical Command in September 2022 with work to be completed primarily in Duarte California United States. The grant has a duration of 4 years and was awarded through assistance program 12.420 Military Medical Research and Development. $1,056,000 (50.0%) of this Project Grant was funded by non-federal sources.

Status
(Ongoing)

Last Modified 5/24/22

Period of Performance
9/1/22
Start Date
8/31/26
End Date
67.0% Complete

Funding Split
$1.1M
Federal Obligation
$1.1M
Non-Federal Obligation
$2.1M
Total Obligated
50.0% Federal Funding
50.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to W81XWH2210331

Additional Detail

Award ID FAIN
W81XWH2210331
SAI Number
None
Award ID URI
None
Awardee Classifications
Nonprofit With 501(c)(3) IRS Status (Other Than An Institution Of Higher Education)
Other
Awarding Office
W81XWH W4PZ USA MED RSCH ACQUIS ACT
Funding Office
W91ZSQ W03J HQ CO USA MED DEV MAT CM
Awardee UEI
NPH1VN32EWN5
Awardee CAGE
069R2
Performance District
32
Senators
Dianne Feinstein
Alejandro Padilla
Representative
Brad Sherman
Modified: 5/24/22